Zuxu Yao
Keine laufenden Positionen mehr
Profil
Zuxu Yao worked as an Associate Director of Research & Development at Adnavance Technologies, Inc. from 2008 to 2009.
He then worked as the Vice President of Assay Development at Nexogen, Inc. from 2012 to 2014.
From 2014 to 2023, he served as the Chief Technical Officer at DermTech, Inc. Dr. Yao holds a doctorate degree from Memorial University of Newfoundland.
Ehemalige bekannte Positionen von Zuxu Yao
| Unternehmen | Position | Ende |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 01.01.2023 |
| Nexogen, Inc. | Corporate Officer/Principal | 01.08.2014 |
Adnavance Technologies, Inc.
 Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Corporate Officer/Principal | 01.12.2009 |
Ausbildung von Zuxu Yao
| Memorial University of Newfoundland | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DERMTECH, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Adnavance Technologies, Inc.
Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Commercial Services |
| Nexogen, Inc. |
